Abstract
AbstractTwo essential key events in acrylamide (ACR) acute neurotoxicity are the formation of adducts with nucleophilic sulfhydryl groups on cysteine residues of selected proteins in the synaptic terminals and the depletion of the glutathione (GSx) stores in neural tissue. The use of N-acetylcysteine (NAC) has been recently proposed as a potential antidote against ACR neurotoxicity, as this chemical is not only a well-known precursor of the reduced form of glutathione (GSH), but also is an scavenger of soft electrophiles such as ACR. In this study, the suitability of 0.3 and 0.75 mM NAC to protect against the neurotoxic effect of 0.75 mM ACR has been testedin vivoin adult zebrafish. NAC provided only a mild to negligible protection against the changes induced by ACR in the motor function, behavior, transcriptome and proteome. The permeability of NAC to cross blood-brain barrier (BBB) was assessed, as well as the ACR-scavenging activity and the gamma-glutamyl-cysteine ligase (γ-GCL) and acylase I activities. The results show that ACR not only depletes GSx levels but also inhibits it synthesis from NAC/cysteine, having a dramatic effect over the glutathione system. Moreover, results indicate a very low NAC uptake to the brain, probably by a combination of low BBB permeability and high deacylation of NAC during the intestinal absorption. These results strongly suggest that the use of NAC is not indicated in ACR acute neurotoxicity treatment.
Funder
Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca
North Atlantic Treaty Organization
Ministry of Economy and Competitiveness | Consejo Superior de Investigaciones Científicas
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Friedman, M. Chemistry, biochemistry, and safety of acrylamide. A review. Journal of agricultural and food chemistry 51, 4504–4526 (2003).
2. Kosharskyy, B. et al. 2-Acetylcyclopentanone, an enolate-forming 1, 3-dicarbonyl compound, is cytoprotective in warm ischemia-reperfusion injury of rat liver. Journal of Pharmacology and Experimental Therapeutics 353, 150–158 (2015).
3. LoPachin, R. M. & Gavin, T. Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry. Environmental health perspectives 120, 1650 (2012).
4. Fujita, A. Clinical observation on 3 cases of acrylamide intoxication. Nippon Iji Shimpo 1869, 37–40 (1960).
5. Auld, R. B. & Bedwell, S. F. Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide. Canadian Medical Association Journal 96, 652 (1967).
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献